These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

28 related articles for article (PubMed ID: 9364208)

  • 1. A Tox21 Approach to Altered Epigenetic Landscapes: Assessing Epigenetic Toxicity Pathways Leading to Altered Gene Expression and Oncogenic Transformation In Vitro.
    Parfett CL; Desaulniers D
    Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28587163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lentivirus-mediated RNA interference targeting the H19 gene inhibits cell proliferation and apoptosis in human choriocarcinoma cell line JAR.
    Yu LL; Chang K; Lu LS; Zhao D; Han J; Zheng YR; Yan YH; Yi P; Guo JX; Zhou YG; Chen M; Li L
    BMC Cell Biol; 2013 May; 14():26. PubMed ID: 23711233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. H19 overexpression in breast adenocarcinoma stromal cells is associated with tumor values and steroid receptor status but independent of p53 and Ki-67 expression.
    Adriaenssens E; Dumont L; Lottin S; Bolle D; Leprêtre A; Delobelle A; Bouali F; Dugimont T; Coll J; Curgy JJ
    Am J Pathol; 1998 Nov; 153(5):1597-607. PubMed ID: 9811352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for multiple steps in neoplastic transformation of normal and preneoplastic Syrian hamster embryo cells following transfection with Harvey murine sarcoma virus oncogene (v-Ha-ras).
    Thomassen DG; Gilmer TM; Annab LA; Barrett JC
    Cancer Res; 1985 Feb; 45(2):726-32. PubMed ID: 2981612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. H19 expression and tumorigenicity of choriocarcinoma derived cell lines.
    Rachmilewitz J; Elkin M; Rosensaft J; Gelman-Kohan Z; Ariel I; Lustig O; Schneider T; Goshen R; Biran H; de Groot N
    Oncogene; 1995 Sep; 11(5):863-70. PubMed ID: 7545806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multistage neoplastic transformation of Syrian hamster embryo cells cultured at pH 6.70.
    LeBoeuf RA; Kerckaert GA; Aardema MJ; Gibson DP
    Cancer Res; 1990 Jun; 50(12):3722-9. PubMed ID: 2340519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chromosome alterations in Syrian hamster cells transformed in vitro by sodium bisulfite, a nonclastogenic carcinogen.
    Popescu NC; DiPaolo JA
    Cancer Res; 1988 Dec; 48(24 Pt 1):7246-51. PubMed ID: 3191496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutational activation of pp60(c-src) leads to a tumorigenic phenotype in a preneoplastic Syrian hamster embryo cell line.
    Lansing TJ; Turk BF; Kanner SB; Gilmer TM
    Cancer Res; 1997 May; 57(10):1962-9. PubMed ID: 9157992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of the H19 gene in Syrian hamster embryo cell tumorigenicity.
    Isfort RJ; Cody DB; Kerckaert GA; Tycko B; LeBoeuf RA
    Mol Carcinog; 1997 Oct; 20(2):189-93. PubMed ID: 9364208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Syrian hamster embryo (SHE) cell transformation system: a biologically relevant in vitro model--with carcinogen predicting capabilities--of in vivo multistage neoplastic transformation.
    Isfort RJ; LeBoeuf RA
    Crit Rev Oncog; 1995; 6(3-6):251-60. PubMed ID: 9012585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell culture models of multistep carcinogenesis.
    Barrett JC
    IARC Sci Publ; 1985; (58):181-202. PubMed ID: 3913638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of oncogenes and tumor suppressor genes in a multistep model of carcinogenesis.
    Barrett JC; Oshimura M; Koi M
    Symp Fundam Cancer Res; 1986; 39():45-56. PubMed ID: 3321309
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.